Jichuan Pharmacy (600566.SH) disclosed the results of Cao Fei's tender offer and will resume trading tomorrow.

Intelligent Financial News APP, Jichuan Pharmaceuticals (600566.SH) announced that during the tender offer period, there were a total of 34 shareholders with a total of 16,300 shares who are expected to accept the offer, accounting for 0.0018% of the total number of shares of the company. Cao Fei will purchase the shares according to the terms of the tender offer. After the completion of the tender offer, Cao Fei will directly and indirectly control 56.07% of the company's shares, and Cao Fei and its concerted action person Cao Longxiang will jointly control 61.15% of the company's shares. After the completion of this tender offer, the distribution of the company's equity still meets the listing requirements and the listing status is not affected. The company's stock will resume trading from July 21st.